Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 363-370, October 2003

Neuroendocrine tumours: clinical presentation and management of localized disease

  • Matthew H Kulke

      Affiliations

    • Corresponding Author InformationCorrespondence to: Matthew H. Kulke MD, Assistant Professor of Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 0215, USA. Tel.: +617-632-5136; Fax: +617-632-5370

Dana-Farber Cancer Institute and Harvard Medical School, Department of Medical Oncology, Boston, MA 0215, USA

Abstract 

Neuroendocrine tumours often present a diagnostic and therapeutic challenge. They can arise almost anywhere in the body, and are therefore associated with a broad range of local symptoms. The systemic manifestations of neuroendocrine tumours are also diverse, and are related to the secretion of numerous hormones and biogenic amines. In recent years, improved diagnostic techniques, increased recognition of neuroendocrine tumour subtypes, and new therapeutic modalities have enhanced clinicians’ ability to detect and appropriately treat these malignancies.

Keywords:  Neuroendocrine tumour, carcinoid, islet cell tumour, pancreatic endocrine tumour, local disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(03)00072-0

doi:10.1016/S0305-7372(03)00072-0

Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 363-370, October 2003